CD44 and neoplasm: Our results indeed show that: (i) CD44 and TF are co-expressed in different human breast EMT+ tumor cell models, (ii) silencing CD44 diminishes TF at the RNA and protein levels, (iii) silencing CD44 decreases the coagulant activity and the metastatic seeding properties of EMT+/TF+ tumor cells.